Home › Esophageal Achalasia › NCT07293689
PREcision MEDicine In Achalasia (PREMEDIA) - Cohort
PREcision MEDicine In Achalasia - A Multicenter Randomized Non-Inferiority Clinical Trial of Short Tailored POEM vs. Standard POEM for Non-Spastic Achalasia and A Multicenter Prospective Cohort Study of Long Tailored POEM for Spastic Esophageal Motility Disorders
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Age ≥ 18 2. Type III achalasia or EGJOO with spastic/hypercontractile features or Jackhammer Esophagus or Distal Esophageal Spasm 3. Eckardt Score \> 3 Exclusion Criteria: * Exclusion: 1. Prior POEM 2. Prior surgical treatment for achalasia 3. Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months 4. Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy 5. Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication 6. Known secondary achalasia related to malignancy (pseudoachalasia) 7. Known eosinophilic esophagitis 8. Diverticulum (\> 2 cm) in distal esophagus 9. Megaesophagus 10. Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic) 11. Pregnancy 12. Standard contraindications to general anesthesia 13. Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices) 14. Unwillingness or inability to consent for the study 15. Anticipated inability to follow protocol
About the study
The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing due to certain conditions. The main question it aims to answer is: does pre-POEM testing help the physician choose how long to cut the muscle.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Sponsor: Northwestern University · Participants: 200 · Started: Dec 1, 2026
Contact the study team
- Elizabeth Yan, BS · Phone: 312-908-1723
- Yasmin Pina, BS · Phone: 312-503-6459
Official record on ClinicalTrials.gov — NCT07293689
Locations in the U.S.
| Arizona | Mayo Clinic Arizona, Scottsdale (Not yet recruiting) |
| California | University of California San Diego, La Jolla (Not yet recruiting) |
| Colorado | University of Colorado Denver, Denver (Not yet recruiting) |
| Florida | University of Florida, Gainesville Adventist Health System/Sunbelt, Inc, Orlando (Not yet recruiting) |
| Georgia | Emory University, Atlanta |
| Illinois | Northwestern University, Chicago |
| Maryland | Johns Hopkins University, Baltimore (Not yet recruiting) |
| Massachusetts | Massachusetts General Hospital, Boston |
| Missouri | Washington University, St Louis (Not yet recruiting) |
| New York | Weill Cornell Medical College, New York (Not yet recruiting) |
| North Carolina | Atrium Health/Wake Forest, Charlotte |
| Ohio | Case Western Reserve University, Cleveland (Not yet recruiting) MetroHealth Medical Center, Cleveland |
| Tennessee | Vanderbilt University Medical Center, Nashville |
| Texas | Baylor Scott & White Health, Dallas (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.